A case report on the effects of COVID-19 on ANC monitoring in a patient on long-term clozapine treatment

• Váldodahkkit: Denton Lauren PharmD (Dahkki), Kapuganti Amber PharmD, BCPP (Dahkki), Kim Sarah MD (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: American Association of Psychiatric Pharmacists, 2023-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background Clozapine carries a US boxed warning for severe neutropenia, and strict monitoring is required through the FDA's Risk Evaluation and Mitigation Strategy (REMS) program. Patients with confirmed diagnosis of COVID-19 are also at risk for neutropenia. For patients on clozapine, the diag...